See other companies on Welcome to the Jungle
Quanthealth
Clinical simulations for drug development
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- Biology
- Machine Learning
- Tel Aviv-Yafo, Tel Aviv District
Jump to section
Company mission
To provide innovative solutions to pharmaceutical and biotechnology companies for de-risking the drug and clinical development process.
Our take
Drug development pipelines are infamously long, with inefficiencies in clinical trial design being a major contributor to lost and wasted time. QuantHealth sets out to change this, with an intelligent platform capable of predicting the outcomes and risks of complex clinical trials, allowing them to be optimized for safety and effectiveness before they are deployed.
With QuantHealth, drug developers can run synthetic trials before real-world ones, which allow them to discover much more quickly and easily if designs are unsafe or suboptimal. This means that the only drugs making it to real-world trials are those that are especially promising, meaning the time, money and manpower associated with trialling is not going to waste.
With the potential to make a real difference to health outcomes, QuantHealth's offering is certainly intriguing. Having raised substantial funding, the company is aiming to expand its platform for preclinical and drug discovery, as well as build out its team with commercial and operations talent.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Annual home office stipend
- Early stage company equity in the form of stock options
- Health, Dental, and Vision insurance
- 401K match
Funding (2 rounds)
Jan 2024
$2m
SERIES A
Aug 2023
$15m
SERIES A
Total funding: $17m
This company has top investors
Leadership
Orr Inbar
(CEO)Has worked as Head of Data Science at Concerto HealthAI, ML/AI Architect at SymphonyAI, and Head of Data Science & Engineering Precision Health AI.
Arnon Horev
(CSO/COO)Was Chief Business Officer at Nucleai, and prior to that worked at Nucleix Ltd as Director of Product Marketing.